School of Medicine, University of St. Gallen, St.Gallen, Switzerland.
Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore.
PLoS One. 2024 Aug 19;19(8):e0301763. doi: 10.1371/journal.pone.0301763. eCollection 2024.
Aging is the strongest risk factor for most chronic diseases. The rising burden of an aging population and non-communicable diseases (NCDs), contributes to escalating costs for society. Several non-pharmaceutical interventions can lower the risk of NCDs, including common mental disorders (CMDs), and may slow down biological aging, as evidenced by outcome markers such as epigenetic clocks. However, a comprehensive overview of whether and which non-pharmaceutical interventions may impact human epigenetic aging is missing. Synthesizing evidence of interventions on epigenetic aging that can be adopted by a wider population is key to guide healthy aging initiatives and to reduce the burden of NCDs and CMDs. This scoping review will identify and assess non-pharmaceutical interventions aimed to slow down epigenetic aging, including their intervention components, and the mode used for intervention delivery.
This protocol will include single- and multicomponent intervention studies that target individuals ≥ 18 years of age and use epigenetic clocks as primary or secondary outcomes. Five electronic databases will be searched for studies between July 2011 until December 2023. The final search will include the search terms adults, non-pharmaceutical interventions, epigenetic aging and their respective synonyms. We will include randomized controlled trials, non-randomized controlled studies, cohort studies, and case-control studies. Additionally, the reference list of other reviews will be screened for relevant articles. Study selection is carried out based on the defined eligibility criteria by two authors. Quality and risk of bias for the included studies will be assessed using the Critical Appraisal Skills Programme (CASP) checklist. Data extraction will include generic key information such as the research question and results, the intervention components, and specific epigenetic outcome measures used. Further data regarding the delivery mode of the treatment protocol will be collected.
This scoping review will summarize the characteristics of non-pharmaceutical intervention studies on epigenetic aging. This review will be the first step to formally identify key intervention components and delivery modes to guide future research on healthy aging interventions. The results will be disseminated through a peer-reviewed publication and presented at relevant conferences. This review will synthesize information from available publications and does not require further ethical approval.
Open Science Framework https://doi.org/10.17605/OSF.IO/FEHNB.
衰老 是大多数慢性疾病的最强危险因素。人口老龄化和非传染性疾病(NCDs)负担的增加,导致社会成本不断上升。几种非药物干预措施可以降低 NCDs 的风险,包括常见的精神障碍(CMDs),并且可能会减缓生物衰老,这可以通过表观遗传时钟等结果标志物来证明。然而,目前还缺乏关于哪些非药物干预措施是否可能影响人类表观遗传衰老的全面概述。综合评估可以被更广泛人群采用的干预措施对表观遗传衰老的影响,是指导健康老龄化计划和减少 NCDs 和 CMDs 负担的关键。本范围综述将确定和评估旨在减缓表观遗传衰老的非药物干预措施,包括其干预组成部分,以及用于干预交付的模式。
该方案将包括针对 18 岁及以上个体的单因素和多因素干预研究,将表观遗传时钟作为主要或次要结果。将在 2011 年 7 月至 2023 年 12 月期间在五个电子数据库中搜索研究。最终搜索将包括成人、非药物干预、表观遗传衰老及其各自同义词的搜索词。我们将包括随机对照试验、非随机对照研究、队列研究和病例对照研究。此外,还将筛选其他综述的参考文献列表以获取相关文章。研究选择是根据两名作者定义的纳入标准进行的。使用批判性评估技能计划 (CASP) 清单评估纳入研究的质量和偏倚风险。数据提取将包括研究问题和结果、干预组成部分以及使用的特定表观遗传结果测量等通用关键信息。还将收集有关治疗方案交付模式的更多数据。
本范围综述将总结关于表观遗传衰老的非药物干预研究的特征。本综述将是正式确定关键干预组成部分和交付模式以指导健康老龄化干预未来研究的第一步。研究结果将通过同行评议的出版物发表,并在相关会议上展示。本综述将综合现有出版物的信息,不需要进一步的伦理批准。
Open Science Framework https://doi.org/10.17605/OSF.IO/FEHNB.